Mitochondrial dysfunction contributes to podocyte injury, which is the leading cause of proteinuria in diabetic nephropathy (DN). In this study, we explored the role of cyclin-dependent kinase 5 (Cdk5) in mitochondrial dysfunction of podocytes under diabetic conditions.
Results:
Our results showed that the expression and activity of Cdk5 were significantly upregulated in vivo and in vitro under diabetic conditions, accompanied by the downregulation of synaptopodin and nephrin, as well as structural and functional mitochondrial dysfunction. Inhibition of Cdk5 with roscovitine or dominant-negative Cdk5 led to the attenuation of podocyte injury by upregulating synaptopodin and nephrin. The inhibition of Cdk5 also ameliorated mitochondrial dysfunction by decreasing reactive oxygen species levels and cytochrome c release, while increasing adenosine triphosphate production. Sirt1, an NAD+-dependent deacetylase, was decreased in podocytes with high glucose (HG) treatment; however, its phosphorylation level at S47 was significantly upregulated. We demonstrated that HG levels cause overactive Cdk5 to phosphorylate Sirt1 at S47. Suppression of Cdk5 reduced Sirt1 phosphorylation levels and mutation of S47 to nonphosphorable alanine (S47A), significantly attenuated podocyte injury and mitochondrial dysfunction in diabetic condition in vivo and in vitro.
Innovation and Conclusion:
Our study has demonstrated the role of Cdk5 in regulating mitochondrial function through Sirt1 phosphorylation and thus can potentially be a new therapeutic target for DN treatment. IRB number: 20190040. Antioxid. Redox Signal. 34, 171–190.
Get full access to this article
View all access options for this article.
References
1.
AhmedHH, TahaFM, OmarHS, ElwiHM, and AbdelnasserM. Hydrogen sulfide modulates SIRT1 and suppresses oxidative stress in diabetic nephropathy. Mol Cell Biochem, 457: 1–9, 2019.
2.
AlcendorRR, GaoS, ZhaiP, ZablockiD, HolleE, YuX, TianB, WagnerT, VatnerSF, and SadoshimaJ. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res, 100: 1512–1521, 2007.
3.
AquilanoK, VigilanzaP, BaldelliS, PaglieiB, RotilioG, and CirioloMR. Peroxisome proliferator-activated receptor gamma co-activator 1alpha (PGC-1alpha) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial biogenesis. J Biol Chem, 285: 21590–21599, 2010.
4.
BaiB, LiangY, XuC, LeeMY, XuA, WuD, VanhouttePM, and WangY. Cyclin-dependent kinase 5-mediated hyperphosphorylation of sirtuin-1 contributes to the development of endothelial senescence and atherosclerosis. Circulation, 126: 729–740, 2012.
BrinkkoetterPT, WuJS, OhseT, KrofftRD, SchermerB, BenzingT, PippinJW, and ShanklandSJ. p35, the non-cyclin activator of Cdk5, protects podocytes against apoptosis in vitro and in vivo. Kidney Int, 77: 690–699, 2010.
8.
CaminsA, VerdaguerE, FolchJ, CanudasAM, and PallasM. The role of CDK5/P25 formation/inhibition in neurodegeneration. Drug News Perspect, 19: 453–460, 2006.
9.
ChauMD, GaoJ, YangQ, WuZ, and GromadaJ. Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway. Proc Natl Acad Sci U S A, 107: 12553–12558, 2010.
10.
ChengK and IpNY. Cdk5: a new player at synapses. Neurosignals, 12: 180–190, 2003.
11.
ChoiSE, KwonS, SeokS, XiaoZ, LeeKW, KangY, LiX, ShinodaK, KajimuraS, KemperB, and KemperJK. Obesity-linked phosphorylation of SIRT1 by Casein Kinase 2 inhibits its nuclear localization and promotes fatty liver. Mol Cell Biol, 37: e00006-17, 2017.
12.
ConradE, Polonio-VallonT, MeisterM, MattS, BitomskyN, HerbelC, LieblM, GreinerV, KriznikB, SchumacherS, Krieghoff-HenningE, and HofmannTG. HIPK2 restricts SIRT1 activity upon severe DNA damage by a phosphorylation-controlled mechanism. Cell Death Differ, 23: 110–122, 2016.
13.
DuannP and LinPH. Mitochondria Damage and Kidney Disease. Adv Exp Med Biol, 982: 529–551, 2017.
14.
DuYG, ZhangKN, GaoZL, DaiF, WuXX, and ChaiKF. Tangshen formula improves inflammation in renal tissue of diabetic nephropathy through SIRT1/NF-κB pathway. Exp Ther Med, 15: 2156–2164, 2018.
15.
EidAA, GorinY, FaggBM, MaaloufR, BarnesJL, BlockK, and AbboudHE. Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. Diabetes, 58: 1201–1211, 2009.
16.
FarmerT, NaslavskyN, and CaplanS. Tying trafficking to fusion and fission at the mighty mitochondria. Traffic, 19: 569–577, 2018.
17.
GalvanDL, LongJ, GreenN, ChangBH, LinJS, SchumackerP, TruongLD, OverbeekP, and DaneshFR. Drp1S600 phosphorylation regulates mitochondrial fission and progression of nephropathy in diabetic mice. J Clin Invest, 129: 2807–2823, 2019.
18.
GuoMY, ShangL, HuYY, JiangLP, WanYY, ZhouQQ, ZhangK, LiaoHF, YiJL, and HanXJ. The role of Cdk5-mediated Drp1 phosphorylation in Abeta1–Abeta42 induced mitochondrial fission and neuronal apoptosis. J Cell Biochem, 119: 4815–4825, 2018.
19.
GuptaKK and SinghSK. Cdk5: a main culprit in neurodegeneration. Int J Neurosci, 129: 1192–1197, 2019.
HorneSJ, VasquezJM, GuoY, LyV, PiretSE, LeonardoAR, LingJ, ReveloMP, BogenhagenD, YangVW, HeJC, and MallipattuSK. Podocyte-specific loss of Kruppel-like factor 6 increases mitochondrial injury in diabetic kidney disease. Diabetes, 67: 2420–2433, 2018.
22.
JangWB, ParkJH, JiST, LeeNK, KimDY, KimYJ, JungSY, KangS, LamichaneS, LamichaneBD, HaJ, YunJ, MoonHR, BaekSH, ChungHY, and KwonSM. Cytoprotective roles of a novel compound, MHY-1684, against hyperglycemia-induced oxidative stress and mitochondrial dysfunction in human cardiac progenitor cells. Oxid Med Cell Longev, 2018: 4528184, 2018.
23.
KumarGS, KulkarniA, KhuranaA, KaurJ, and TikooK. Selenium nanoparticles involve HSP-70 and SIRT1 in preventing the progression of type 1 diabetic nephropathy. Chem Biol Interact, 223: 125–133, 2014.
24.
KumazawaA, MitaN, HirasawaM, AdachiT, SuzukiH, ShafeghatN, KulkarniAB, MikoshibaK, InoueT, and OhshimaT. Cyclin-dependent kinase 5 is required for normal cerebellar development. Mol Cell Neurosci, 52: 97–105, 2013.
LeeSE, JangJE, KimHS, JungMK, KoMS, KimMO, ParkHS, OhW, ChoiSJ, JinHJ, KimSY, KimYJ, KimSW, KimMK, SungCO, PackCG, LeeKU, and KohEH. Mesenchymal stem cells prevent the progression of diabetic nephropathy by improving mitochondrial function in tubular epithelial cells. Exp Mol Med, 51: 77, 2019.
27.
LiQ, DongZ, LianW, CuiJ, WangJ, ShenH, LiuW, YangJ, ZhangX, and CuiH. Ochratoxin A causes mitochondrial dysfunction, apoptotic and autophagic cell death and also induces mitochondrial biogenesis in human gastric epithelium cells. Arch Toxicol, 93: 1141–1155, 2019.
28.
LinYC, ChangYH, YangSY, WuKD, and ChuTS. Update of pathophysiology and management of diabetic kidney disease. J Formos Med Assoc, 117: 662–675, 2018.
29.
LiuR, ZhongY, LiX, ChenH, JimB, ZhouMM, ChuangPY, and HeJC. Role of transcription factor acetylation in diabetic kidney disease. Diabetes, 63: 2440–2453, 2014.
30.
LiuW, ZhangY, HaoJ, LiuS, LiuQ, ZhaoS, ShiY, and DuanH. Nestin protects mouse podocytes against high glucose-induced apoptosis by a Cdk5-dependent mechanism. J Cell Biochem, 113: 3186–3196, 2012.
31.
LiuW, ZhouY, LiangR, and ZhangY. Inhibition of cyclin-dependent kinase 5 activity alleviates diabetes-related cognitive deficits. FASEB J, 33: 14506–14515, 2019.
32.
MaY, ChenZ, TaoY, ZhuJ, YangH, LiangW, and DingG. Increased mitochondrial fission of glomerular podocytes in diabetic nephropathy. Endocr Connect, 8: 1206–1212, 2019.
33.
MarshallCB and ShanklandSJ. Cell cycle regulatory proteins in podocyte health and disease. Nephron Exp Nephrol, 106: e51–e59, 2007.
34.
MorigiM, PericoL, and BenigniA. Sirtuins in renal health and disease. J Am Soc Nephrol, 29: 1799–1809, 2018.
35.
MorishimaM, HorikawaK, and FunakiM. Cardiomyocytes cultured on mechanically compliant substrates, but not on conventional culture devices, exhibit prominent mitochondrial dysfunction due to reactive oxygen species and insulin resistance under high glucose. PLoS One, 13: e0201891, 2018.
36.
NikhilK and ShahK. The Cdk5-Mcl-1 axis promotes mitochondrial dysfunction and neurodegeneration in a model of Alzheimer's disease. J Cell Sci, 130: 3023–3039, 2017.
37.
PagtalunanME, MillerPL, Jumping-EagleS, NelsonRG, MyersBD, RennkeHG, CoplonNS, SunL, and MeyerTW. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest, 99: 342–348, 1997.
38.
Papadopoulou-MarketouN, PaschouSA, MarketosN, AdamidiS, AdamidisS, and Kanaka-GantenbeinC. Diabetic nephropathy in type 1 diabetes. Minerva Med, 109: 218–228, 2018.
39.
PavenstadtH, KrizW, and KretzlerM. Cell biology of the glomerular podocyte. Physiol Rev, 83: 253–307, 2003.
40.
SongH, KimW, ChoiJH, KimSH, LeeD, ParkCH, KimS, KimDY, and KimKT. Stress-induced nuclear translocation of CDK5 suppresses neuronal death by downregulating ERK activation via VRK3 phosphorylation. Sci Rep, 6: 28634, 2016.
41.
SuM, DhoopunAR, YuanY, HuangS, ZhuC, DingG, LiuB, YangT, and ZhangA. Mitochondrial dysfunction is an early event in aldosterone-induced podocyte injury. Am J Physiol Renal Physiol, 305: F520–F531, 2013.
42.
SunZ, MaY, ChenF, WangS, ChenB, and ShiJ. miR-133b and miR-199b knockdown attenuate TGF-β1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy. Eur J Pharmacol, 837: 96–104, 2018.
43.
SusztakK, RaffAC, SchifferM, and BottingerEP. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes, 55: 225–233, 2006.
44.
TaniguchiY, PippinJW, HagmannH, KrofftRD, ChangAM, ZhangJ, TeradaY, BrinkkoetterP, and ShanklandSJ. Both cyclin I and p35 are required for maximal survival benefit of cyclin-dependent kinase 5 in kidney podocytes. Am J Physiol Renal Physiol, 302: F1161–F1171, 2012.
45.
TeikenJM, AudetteyJL, LaturnusDI, ZhengS, EpsteinPN, and CarlsonEC. Podocyte loss in aging OVE26 diabetic mice. Anat Rec (Hoboken), 291: 114–121, 2008.
46.
WangJ, DongZH, GuiMT, YaoL, LiJH, ZhouXJ, and FuDY. HuoXue QianYang QuTan Recipe attenuates left ventricular hypertrophy in obese hypertensive rats by improving mitochondrial function through SIRT1/PGC-1alpha deacetylation pathway. Biosci Rep, 39: BSR20192909, 2019.
47.
WangW, WangY, LongJ, WangJ, HaudekSB, OverbeekP, ChangBH, SchumackerPT, and DaneshFR. Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells. Cell Metab, 15: 186–200, 2012.
48.
WangXL, WuLY, ZhaoL, SunLN, LiuHY, LiuG, and GuanGJ. SIRT1 activator ameliorates the renal tubular injury induced by hyperglycemia in vivo and in vitro via inhibiting apoptosis. Biomed Pharmacother, 83: 41–50, 2016.
49.
WeiPZ and SzetoCC. Mitochondrial dysfunction in diabetic kidney disease. Clin Chim Acta, 496: 108–116, 2019.
50.
WikstromJD, MahdavianiK, LiesaM, SeredaSB, SiY, LasG, TwigG, PetrovicN, ZingarettiC, GrahamA, CintiS, CorkeyBE, CannonB, NedergaardJ, and ShirihaiOS. Hormone-induced mitochondrial fission is utilized by brown adipocytes as an amplification pathway for energy expenditure. EMBO J, 33: 418–436, 2014.
51.
YangS, HanY, LiuJ, SongP, XuX, ZhaoL, HuC, XiaoL, LiuF, ZhangH, and SunL. Mitochondria: a novel therapeutic target in diabetic nephropathy. Curr Med Chem, 24: 3185–3202, 2017.
52.
YeT, FuAK, and IpNY. Cyclin-dependent kinase 5 in axon growth and regeneration. Int Rev Neurobiol, 105: 91–115, 2012.
53.
YoshizakiT, MilneJC, ImamuraT, SchenkS, SonodaN, BabendureJL, LuJC, SmithJJ, JirousekMR, and OlefskyJM. SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol Cell Biol, 29: 1363–1374, 2009.
54.
ZebA, KimD, AlamSI, SonM, KumarR, RampoguS, ParameswaranS, ShelakeRM, RanaRM, ParateS, KimJY, and LeeKW. Computational simulations identify pyrrolidine-2,3-dione derivatives as novel inhibitors of Cdk5/p25 complex to attenuate Alzheimer's Pathology. J Clin Med, 8: 746, 2019.
55.
ZhangY, LiH, HaoJ, ZhouY, and LiuW. High glucose increases Cdk5 activity in podocytes via transforming growth factor-beta1 signaling pathway. Exp Cell Res, 326: 219–229, 2014.
56.
ZhangZ, ZhaoR, TangY, WenS, WangD, and QiJ. Fuzhisan, a Chinese herbal medicine, inhibits beta-amyloid-induced neurotoxicity and tau phosphorylation through calpain/Cdk5 pathway in cultured cortical neurons. Neurochem Res, 36: 801–811, 2011.
57.
ZhengYL, ZhangX, FuHX, GuoM, ShuklaV, Amin NDE J, BaoL, LuoHY, LiB, LuXH, and GaoYC. Knockdown of Expression of Cdk5 or p35 (a Cdk5 Activator) Results in Podocyte Apoptosis. PLoS One, 11: e0160252, 2016.
58.
ZhouD, ZhouM, WangZ, FuY, JiaM, WangX, LiuM, ZhangY, SunY, LuY, TangW, and YiF. PGRN acts as a novel regulator of mitochondrial homeostasis by facilitating mitophagy and mitochondrial biogenesis to prevent podocyte injury in diabetic nephropathy. Cell Death Dis, 10: 524, 2019.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
